Roche is helping labs improve patient care with high medical value assays that provide critical, actionable insights to inform therapeutic decisions for treating cancer. Our high medical value assays and companion diagnostics solutions are ready to use and are fully automated to streamline workflow and ensure patient safety.
Roche offers the largest menu of ready-to-use IHC assays across disease states, including predictive assays with the greatest number of therapies on label. Our leading portfolio of companion diagnostics represents access to a broad range of cancer therapies.
Ready-to-use reagents
Pre-diluted for consistent and reproducible results
Individual protocol tunability
To achieve optimal staining intensity for each marker
Fully automated
Optimized for use on BenchMark systems
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.
You are now leaving the website of Hoffmann-La Roche Ltd. ("Roche Canada"). Links to all external sites are provided as a resource to our visitors. Roche Canada assumes no responsibility for the content of these sites. Roche Canada has no control over these sites and the opinions, claims or comments contained in these sites should not be attributed to Roche Canada, unless otherwise specified.